Respiratory syncytial virus infection : survival experience in a cohort of children inpatients

Copyright © 2023 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved..

OBJECTIVE: The objective of this study was to assess the survival experience of children hospitalized with laboratory-confirmed respiratory syncytial virus (RSV) infection due to bronchiolitis.

STUDY DESIGN: This was a nationwide retrospective cohort study conducted in Mexico.

METHODS: We analyzed data from 436 children aged 5 years and younger, with symptom onset between August 2021 and November 2022. The Kaplan-Meier method was used to compute survivor functions and their 95% confidence intervals (CI).

RESULTS: High survival rates were observed, particularly within the first three weeks of hospital admission. The 3-day survival rate was 99.8% (CI 98.4-99.9%), which decreased to 98.9% (CI 96.5-99.7%), 97.5% (CI 91.9-99.3%), 86.7% (CI 48.2-97.2%), and 69.4% (CI 24.2-91.0%) on days 7, 14, 21, and 28 of hospital stay, respectively. We documented a total of 5 fatal outcomes, resulting in a mortality rate of 2.1 (95% CI 0.9-5.1) per 1,000 person-days.

CONCLUSIONS: Our study analyzed a large cohort of pediatric patients with bronchiolitis caused by RSV infection, providing valuable insights into the in-hospital progression of this disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:221

Enthalten in:

Public health - 221(2023) vom: 05. Aug., Seite 181-183

Sprache:

Englisch

Beteiligte Personen:

Murillo-Zamora, E [VerfasserIn]
Mendoza-Cano, O [VerfasserIn]
Huerta, M [VerfasserIn]
Ríos-Silva, M [VerfasserIn]
Lugo-Radillo, A [VerfasserIn]
Benites-Godínez, V [VerfasserIn]
Bricio-Barrios, J A [VerfasserIn]
Ríos-Bracamontes, E F [VerfasserIn]
Trujillo, X [VerfasserIn]

Links:

Volltext

Themen:

Bronchiolitis
Child
Journal Article
Respiratory syncytial virus infections
Survival

Anmerkungen:

Date Completed 08.08.2023

Date Revised 08.08.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.puhe.2023.06.020

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM359740863